Literature DB >> 2115303

[14C]urea and 58Co-EDTA as reference indicators in hepatic multiple indicator dilution studies.

K S Pang1, F Barker, A J Schwab, C A Goresky.   

Abstract

The space distribution and the processes underlying uptake of tracer substrate may be appraised by the multiple indicator dilution technique, after the simultaneous injection of noneliminated vascular (51Cr-labeled red blood cells), extracellular (125I-labeled albumin and [14C]sucrose for high and low molecular weight interstitial space, respectively), and cellular (3H2O) indicators and tracer substrate. When tracer substrates and/or their metabolites containing 14C or 3H labels are being studied, it becomes necessary to find substitutions for the similarly labeled noneliminated indicators. In red blood cell-perfused rat livers, 58Co-EDTA is found to be a good replacement for the low molecular weight interstitial reference; it has a space distribution indistinguishable from that for [14C]sucrose. [14C]urea and 3H2O, which distribute similarly in red blood cells, have similar outflow dilution profiles. With corrections for minor deviations in recovery [a ratio of 0.936 +/- 0.024 (SD)] and transit time [a ratio of 0.962 +/- 0.008 (SD)], the cellular water space can be closely approximated from the [14C]-urea curve. 58Co-EDTA and [14C]urea are reasonable substitutes for [14C]sucrose and 3H2O, respectively, in multiple indicator dilution liver perfusion studies for investigating transfer and removal characteristics of tracer substrates.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2115303     DOI: 10.1152/ajpgi.1990.259.1.G32

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  8 in total

1.  A comparative investigation of hepatic clearance models: predictions of metabolite formation and elimination.

Authors:  M V St-Pierre; P I Lee; K S Pang
Journal:  J Pharmacokinet Biopharm       Date:  1992-04

2.  Discrepancies in pharmacokinetic parameter estimation between bolus and infusion studies in the perfused rat hindlimb.

Authors:  A C Heatherington; M Rowland
Journal:  J Pharmacokinet Biopharm       Date:  1995-10

3.  Regional drug delivery I: permeability characteristics of the rat 6-day-old air pouch model of inflammation.

Authors:  S W Martin; A J Stevens; B S Brennan; M L Reis; L A Gifford; M Rowland; J B Houston
Journal:  Pharm Res       Date:  1995-12       Impact factor: 4.200

4.  Imaging of blood flow using hyperpolarized [(13)C]urea in preclinical cancer models.

Authors:  Cornelius von Morze; Peder E Z Larson; Simon Hu; Kayvan Keshari; David M Wilson; Jan Henrik Ardenkjaer-Larsen; Andrei Goga; Robert Bok; John Kurhanewicz; Daniel B Vigneron
Journal:  J Magn Reson Imaging       Date:  2011-03       Impact factor: 4.813

5.  Estimation of aqueous distributional spaces in the dual perfused rat liver.

Authors:  S Sahin; M Rowland
Journal:  J Physiol       Date:  2000-10-01       Impact factor: 5.182

6.  Binding and distribution of three prototype calcium channel blockers in perfused rat liver.

Authors:  A B Bikhazi; K M Bitar; S I Kreydiyyeh; R S Saleh; M M el-Kasti; M Z Ibrahim; O R Abu Khoudoud
Journal:  Mol Cell Biochem       Date:  1997-04       Impact factor: 3.396

7.  Estimation of hepatic distributional volumes using non-labeled reference markers.

Authors:  Yasemin Karabey; Selma Sahin
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2006 Oct-Dec       Impact factor: 2.441

8.  Reversible inhibition of urea exchange in rat hepatocytes.

Authors:  R M Effros; E Jacobs; A Hacker; K Ozker; C Murphy
Journal:  J Clin Invest       Date:  1993-06       Impact factor: 14.808

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.